Alpha Scientific Report issue

For profit Phase 3
Founded: La Verne CA United States (1998)
Status: Acquired by Henry Schein, Inc (2011) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2020
NCT04457297
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Alpha-A, Inc.